R.M. Abra
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 20
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- C. Anthony Hunt (6 shared papers)Jan Vaage (4 shared papers)Peter K. Working (3 shared papers)Peter J. Quinn (2 shared papers)Paul S. Uster (3 shared papers)Emilio Barberá‐Guillem (1 shared paper)Kevin Joseph Harrington (2 shared papers)J.S.W. Stewart (2 shared papers)
- Journals
- Journal of Liposome Research (3 papers)Cancer (3 papers)British Journal of Cancer (2 papers)International Journal of Pharmaceutics (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
R.M. Abra
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 64
- Biomaterials 717
- Drug Discovery 5
- Pharmaceutical Science 61
- Biochemistry 46
- Radiology, Nuclear Medicine and Imaging 109
Countries citing papers authored by R.M. Abra
This map shows the geographic impact of R.M. Abra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M. Abra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M. Abra more than expected).
Fields of papers citing papers by R.M. Abra
This network shows the impact of papers produced by R.M. Abra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M. Abra. The network helps show where R.M. Abra may publish in the future.
Co-authors
The 25 scholars most cited alongside R.M. Abra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 216 | |
| 2 | 1994 | 148 | |
| 3 | 1993 | 92 | |
| 4 | 2000 | 87 | |
| 5 | 2000 | 85 | |
| 6 | 2001 | 75 | |
| 7 | 1994 | 66 | |
| 8 | 2002 | 60 | |
| 9 | 1984 | 52 | |
| 10 | 1975 | 44 | |
| 11 | 1999 | 43 | |
| 12 | 1989 | 41 | |
| 13 | 1992 | 41 | |
| 14 | Liposome disposition in vivo: effects of pre-dosing with lipsomes. | 1980 | 34 |
| 15 | 1990 | 25 | |
| 16 | 1976 | 23 | |
| 17 | 1992 | 21 | |
| 18 | The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker. | 1982 | 19 |
| 19 | 1976 | 18 | |
| 20 | 1989 | 17 |
About R.M. Abra
R.M. Abra is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Biochemistry, Occupational Therapy and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Inhalation and Respiratory Drug Delivery (4 papers), Infection Control in Healthcare (2 papers), Lipid metabolism and biosynthesis (2 papers), Safe Handling of Antineoplastic Drugs (2 papers), Lipid Membrane Structure and Behavior (1 paper) and Neonatal Respiratory Health Research (1 paper). The work is most often cited by research in Biomaterials (717 citations), Drug Discovery (5 citations), Pharmaceutical Science (61 citations), Biochemistry (46 citations) and Radiology, Nuclear Medicine and Imaging (109 citations). R.M. Abra has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include C. Anthony Hunt, Jan Vaage, Peter K. Working, Peter J. Quinn, Paul S. Uster, Emilio Barberá‐Guillem, Kevin Joseph Harrington, J.S.W. Stewart, Gail Rowlinson‐Busza and Konstantinos Nikolaos Syrigos. Their work appears in journals such as Journal of Liposome Research, Cancer, British Journal of Cancer, International Journal of Pharmaceutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.